title: Oral azithromycin for the treatment of meibomitis.
authors.affiliation: Department of Ophthalmology, University of California, San Francisco5now with the Department of Ophthalmology and Visual Science, University of Michigan Kellogg Eye Center, Ann Arbor.
authors.forename: Jonathan B
authors.initials: JB
authors.lastname: Greene
authors.affiliation: Department of Ophthalmology, University of California, San Francisco2Francis I. Proctor Foundation, University of California, San Francisco3Department of Ophthalmology, San Francisco General Hospital, San Francisco, California.
authors.forename: Bennie H
authors.initials: BH
authors.lastname: Jeng
authors.affiliation: Barnet-Dulaney-Perkins Eye Center, Phoenix, Arizona.
authors.forename: Robert E
authors.initials: RE
authors.lastname: Fintelmann
authors.affiliation: Department of Ophthalmology, University of California, San Francisco2Francis I. Proctor Foundation, University of California, San Francisco.
authors.forename: Todd P
authors.initials: TP
authors.lastname: Margolis
mesh_terms: D000284:Administration, Oral; D000900:Anti-Bacterial Agents / Q000008:administration & dosage* / Q000009:adverse effects; D017963:Azithromycin / Q000008:administration & dosage* / Q000009:adverse effects; D001762:Blepharitis / Q000188:drug therapy*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008537:Meibomian Glands / Q000187:drug effects*; D008875:Middle Aged; D012189:Retrospective Studies; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents; D017963:Azithromycin